Interventional cardiology and the medical devices industry: is there a conflict of interest?Martyn Thomas
King s College Hospital, Denmark Hill, London SE5 9RS, UK
Heart 93:1351-2. 2007
One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valveMartyn Thomas
Director of Cardiovascular Services, Cardiology Department, St Thomas Hospital, Westminster Bridge Rd, London, UK
Circulation 124:425-33. 2011
..Transcatheter aortic valve implantation was developed to provide a therapeutic option for patients considered to be ineligible for, and to mitigate mortality and morbidity associated with, high-risk surgical aortic valve replacement...
- The global experience with percutaneous aortic valve replacement
Martyn Thomas
Cardiovascular Services, Guys and St Thomas Hospital, London, UK
JACC Cardiovasc Interv 3:1103-9. 2010
..This review describes the current data with this technology and also the potential for the future role of the technology, including potential ways to yet further improve the short- and longer-term results...
- Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
Martyn Thomas
St Thomas Hospital, London, UK
Circulation 122:62-9. 2010
..The Edwards SAPIEN valve was approved for transcatheter aortic valve implantation transfemoral delivery in the European Union in November 2007 and for transapical delivery in January 2008...
- Brachytherapy: here today, gone tomorrow?
M R Thomas
Department of Cardiology, King s College Hospital, London SE5 9RS, UK
Heart 91:iii32-4. 2005
- Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results
Vinayak Bapat
Department of Cardiothoracic Surgery and Cardiology, Guys and St Thomas Hospital, London, United Kingdom
J Thorac Cardiovasc Surg 144:1372-9; discussion 1379-80. 2012
..We report our experience with transcatheter aortic valve implantation in the treatment of degenerated biologic aortic valve prostheses and discuss factors that can influence the outcome...
- The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation?
Olaf Wendler
Department of Cardiothoracic Surgery, King s Health Partners, London, UK
Eur J Cardiothorac Surg 39:853-9; discussion 859-60. 2011
..Using the SOURCE Registry, we analyze the learning curve for TA-AVI over the first 2 years after commercialization...
- Transapical aortic valve implantation: mid-term outcome from the SOURCE registry
Olaf Wendler
Department of Cardiothoracic Surgery, King s Health Partners, London, UK
Eur J Cardiothorac Surg 43:505-12. 2013
..Transapical (TA) aortic valve implantation using the Edwards SAPIEN™ bioprosthesis was commercially introduced in Europe in January 2008. Limited data on the mid-term results are available...
- Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry
Olaf Wendler
Department of Cardiothoracic Surgery, King s Health Partners, London, UK
Eur J Cardiothorac Surg 38:119-27. 2010
..Currently, the results of trans-apical trans-catheter procedures performed outside controlled trials are unknown...
- Distribution of calcium in the ascending aorta in patients undergoing transcatheter aortic valve implantation and its relevance to the transaortic approach
Vinayak N Bapat
Department of Cardiothoracic Surgery, St Thomas Hospital, London, United Kingdom
JACC Cardiovasc Interv 5:470-6. 2012
..This study sought to identify how many patients suitable for transcatheter aortic valve implantation (TAVI) would have a contraindication for the transaortic (TAo) approach due to ascending aortic calcification...
- Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2
Bernard Chevalier
Institut Cardiovasculaire Paris Sud, Massy Quincy, France
Circ Cardiovasc Interv 2:188-95. 2009
..The newly developed Nobori coronary stent coated with a bioresorbable polymer, polylactic acid, and the antiproliferative agent Biolimus A9 has the potential to reduce restenosis by suppressing neointima formation...
Angiographic and clinical restenosis following the use of long coronary WallstentsI L Williams
Department of Cardiology, King s College Hospital, London, England
Catheter Cardiovasc Interv 48:287-93; discussion 294-5. 1999
..The Wallstent can be deployed in complex lesions with a high primary success rate and an acceptably low restenosis rate. The optimal management of in-stent restenosis remains to be defined...
- Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach
Vinayak Bapat
Department of Cardiothoracic Surgery, Guy s and St Thomas Hospital, London, United Kingdom
Catheter Cardiovasc Interv 79:733-40. 2012
..To evaluate feasibility and outcome of Transoartic Transcatheter Sapien valve implantation...
- First successful trans-catheter aortic valve implantation through ascending aorta using Edwards SAPIEN THV system
Vinayak Bapat
Department of Cardiothoracic Surgery and Cardiology, Guy s and St Thomas Hospital, London, UK
Eur J Cardiothorac Surg 38:811-3. 2010
..We describe a case where conventional trans-catheter approaches, that is, transfemoral or trans-apical using the Edwards THV system, were not possible but successful implantation was achieved through the trans-aortic route...
- Intravascular ultrasound-guided stenting in long lesions: an insight into possible mechanisms of restenosis and comparison of angiographic and intravascular ultrasound data from the MUSIC and RENEWAL trials
T Nageh
King s College Hospital, Denmark Hill, London, England SE5 9RS
J Interv Cardiol 14:397-405. 2001
..Therefore, suboptimal stent deployment due to constraint by lesion resistance may be an important mechanism underlying the high restenosis rates in long stents...
- Warfarin-induced skin necrosis and heparin-induced thrombocytopenia following mitral valve replacement for marantic endocarditis
Craig A White
King s College Hospital, London, UK
J Heart Valve Dis 15:716-8. 2006
..Thrombophilia in the face of endocarditis should be treated with a suspicion of underlying cancer...
- Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial
Divaka Perera
Cardiovascular Division, King s College London, London SE1 7EH, UK
JAMA 304:867-74. 2010
..To date, this assertion has not been tested in a randomized trial...
- A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study
T Nageh
Department of Cardiology, King s College Hospital, London, UK
Am Heart J 141:971-6. 2001
..By comparing the outcome of treating long lesions with two different stent types, we aimed to assess the influence of stent design rather than the nature of long lesions per se on the relatively high restenosis rates in this subgroup...
- Non-flow limiting dissection leading to late coronary restenosis following intracoronary brachytherapy
D R McClean
King's College Hospital, London, UK
Catheter Cardiovasc Interv 54:355-7. 2001
..No dissection was seen immediately following the initial procedure. Subsequent late healing of the dissection led to marked restenosis and the development of angina 14 months after the index procedure...
- Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease
T Nageh
Department of Cardiology, King s College Hospital, Denmark Hill, London SE5 9RS, UK
Heart 91:1181-5. 2005
..To assess the role of cardiac troponin I (cTnI) in predicting outcome after percutaneous coronary intervention (PCI)...
- High-speed rotational atherectomy in the treatment of bifurcation-type coronary lesions
T Nageh
King's College Hospital, London, UK
Cardiology 95:198-205. 2001
..01). Outcome at follow-up favoured the HSRA/stent group, although the difference did not reach statistical significance. CONCLUSION: HSRA with provisional stenting provided a safe and effective means of treating bifurcation lesions...
- Coronary artery perforation during percutaneous intervention: incidence and outcome
M G Gunning
Department of Cardiology, Kings College Hospital, London, UK
Heart 88:495-8. 2002
..To examine the clinical outcome of percutaneous coronary intervention where the procedure was complicated by vessel perforation...
- Recent advances in percutaneous coronary intervention
Arun Patil
Hosp Med 64:132-3. 2003
- Life-threatening coronary artery spasm following sirolimus-eluting stent deployment
Stephen Wheatcroft
J Am Coll Cardiol 47:1911-2; author reply 1912-3. 2006
- Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
Yves Louvard
Institut Cardiovasculaire Paris Sud, Massy, France
Catheter Cardiovasc Interv 71:175-83. 2008
..They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented...
- Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)
Juergen vom Dahl
Medizinische Klinik I, Universitatsklinikum, Rheinisch Westfaelische Technische Hochschule Aachen, Germany
Circulation 105:583-8. 2002
....
- Revascularization for ischemic LV dysfunction: stents or surgery?
Martyn Thomas
Catheter Cardiovasc Interv 70:34. 2007
